Pregnant women with a history of bariatric surgery may have an increased risk of preterm birth.
New guidelines support use of metabolic surgery as standard treatment option for type 2 diabetes, obesityJune 01, 2016
A panel of experts has recommended that metabolic surgery be included as a treatment option for patients with type 2 diabetes and obesity.
Patients who were obese and underwent bariatric surgery saw a significant reduction in heart failure-related exacerbation events.
Patients with psoriasis or psoriatic arthritis who undergo bariatric surgery may see significant improvements in disease severity.
A patient visits her primary care physician for a two-year follow-up after a Roux-en-Y gastric bypass surgery to check for complications.
Significantly fewer ED visits or hospitalizations for asthma exacerbation occurred within 12 months after bariatric surgery.
Both bariatric surgery and intensive weight management yielded similar improvements in HbA1c, weight loss and quality of life.
The rate of diabetes decreased for up to seven years after bariatric surgery for obese patients.
Better glycemic control, lower medication use among obese patients with diabetes who undergo bariatric surgery.
Bariatric surgery may induce type 2 diabetes remission in obese patients, but more direct evidence is needed.
Bariatric surgery for diabetes management offers a quick fix, but does not address the underlying behaviors that cause the disease in the first place.
Significantly more patients achieve glycemic control with surgery plus medical therapy than with medication alone.
Obese patients that underwent any type of bariatric surgery experienced fewer incidences of heart attack and stroke and reduced cardiovascular-related mortality.
Obese adults are at risk for many serious health conditions, including diabetes, coronary heart disease, hypertension, stroke, obstructive sleep apnea (OSA), depression and liver disease.
Following gastric bypass surgery, many patients will still need metformin or glipizide (Glucotrol). Is there any evidence that one class of hypoglycemic agents is better absorbed than another?
As obesity rates continue to rise, primary-care clinicians remain integral in assessing, diagnosing, and treating this worldwide epidemic.
Recent reports address the health benefits of bariatric surgery just as the FDA expands use of the gastric-banding system for weight loss.
Almost half of patients who underwent laparoscopic adjustable gastric banding surgery had their bands removed and many experienced complications in the 12 or more years after the procedure.